Sector Intelligence · Animal Health · June 2026
Animal Health Investment 2026
UK and global animal health market data, private equity deal activity and investment opportunities across veterinary services, animal pharmaceuticals and diagnostics — for investors and family offices.
Market Data
The Numbers Shaping Animal Health in 2026
$5.0bn
UK animal healthcare sector projected market size in 2026, growing to $7.5 billion by 2036 at a CAGR of 4.1%.
Source: Future Market Insights January 2026
$3.63bn
UK veterinary healthcare market size in 2026, growing at a CAGR of 7.38% to reach $5.17 billion by 2031.
Source: Mordor Intelligence January 2026
44.9%
Share of UK veterinary healthcare market accounted for by dogs and cats in 2025, supported by 13.5 million dogs and 12.5 million cats in the UK.
Source: Mordor Intelligence 2026
7.8%
Projected CAGR of the UK veterinary medicine market from 2025 to 2030, driven by rising pet ownership and innovation in veterinary medicine.
Source: Grand View Research 2026
Investment Landscape
The Animal Health Market in 2026
Animal health has established itself as one of the most resilient sub-sectors in healthcare private equity — combining non-cyclical demand from companion animal owners, structural consolidation opportunity across fragmented veterinary practice networks and increasingly sophisticated clinical capabilities including oncology, orthopaedics and advanced diagnostics.
Mars Petcare's 2025 purchase of Linnaeus adds referral depth to its first-opinion network, illustrating multilevel integration strategies — combining GP practices, specialist referral centres and diagnostics under one ownership structure.
The Dechra Pharmaceuticals acquisition by Swedish PE firm EQT — agreed June 2023 — remains the landmark transaction in UK animal health private equity, with Dechra generating 74.6% of its revenue from companion animal products at time of acquisition.
What Investors Are Targeting
Assets Attracting Capital in Animal Health
Companion Animal Clinic Networks
Buy-and-build consolidation of independent veterinary practices into regional and national platforms. Veterinary hospitals and clinics held 55.88% of UK veterinary healthcare revenue in 2025, while point-of-care settings recorded the fastest projected CAGR at 8.43% through 2031.
Animal Diagnostics
Investment in diagnostics aligns with evidence-based protocols that lower drug overuse and improve outcomes, anchoring recurring consumables revenue. AI platforms classify cytology slides in under eight minutes, enabling same-day oncology interventions. As practice groups aggregate, bulk procurement of analysers lowers per-test costs.
Animal Health Pharma
Veterinary pharmaceutical businesses — particularly those focused on companion animal therapeutics with strong patent protection, regulatory moats and premium pricing — attract both PE and strategic acquirer interest.
Key Risks
Risks for Animal Health Investors in 2026
- CMA scrutiny of veterinary practice consolidation — the CMA launched an investigation into the UK veterinary services market in 2023 and published findings in 2024 raising concerns about consolidation and pricing
- Pet ownership normalisation post-pandemic reducing demand growth rates
- Workforce shortages of qualified veterinary surgeons limiting practice capacity
- Regulatory changes to veterinary medicine approvals under the Veterinary Medicines Directorate
Subscribe
Stay Informed on Healthcare Investment
Subscribe to Healthcare Investor Magazine — independent investment intelligence for investors, family offices and private wealth owners.
FAQs
Frequently Asked Questions
Related Sectors
Explore Other Investment Sectors
Published for informational purposes only. Does not constitute financial or investment advice. All data sourced from primary institutional sources as cited. Seek independent professional advice before making any investment decision.
UK Animal Health Investment — The 2026 Landscape
UK veterinary and animal health has become one of the most actively consolidated sub-sectors in UK healthcare M&A. Private equity has driven a sustained buy-and-build wave across veterinary practice networks, specialist referral centres, animal diagnostics and veterinary pharmaceutical distribution — attracting CMA scrutiny while continuing to generate significant transaction volumes. Mars Petcare, CVS Group and IVC Evidensia are among the dominant consolidators in UK first-opinion veterinary practice. AI veterinary diagnostics — including remote imaging interpretation, pattern recognition in clinical pathology and AI-assisted surgical planning — represents the highest-premium sub-category in the current investment cycle, according to Mordor Intelligence and Grand View Research 2026. The UK veterinary market is estimated at several billion pounds annually and remains structurally fragmented despite consolidation, with thousands of independent practice owners representing ongoing acquisition targets for PE platforms. Healthcare Investor Magazine covers UK animal health investment as a core sector — tracking M&A transactions, funding rounds, regulatory developments and market analysis across veterinary services, animal diagnostics, animal pharmaceuticals and pet insurance. All content is independently produced with no advertiser influence on editorial coverage.